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Pluripotent stem cells (PSCs) are specialized cells, which have remarkable ability to maintain in 
an undifferentiated state and are capable of undergoing differentiation to three germ-layer 
lineage cell types, under differentiation-enabling conditions. PSCs include embryonic stem 
(ES)-cells, embryonal carcinoma (EC)-cells and embryonic germ (EG)-cells. ES-cells are 
derived from the inner cell mass (ICM) of day 3.5 blastocysts (mouse). On the other hand, EC- 
and EG-cells have different source of origin and exhibit some differences in terms of their 
differentiation abilities and culture requirements. These PSCs act as an ideal in-vitro model 
system to study early mammalian development and cell differentiation and, they could 
potentially be used for experimental cell-based therapy for a number of diseases. However, one 
of the problems encountered is the immune rejection of transplanted cells. For this, immune-
matched induced pluripotent stem (iPS)-cells have been derived from somatic cells, by forced 
expression of a few stemness genes. Although, human PSCs lines are being experimented, their 
cell-therapeutic potential is still far from being thoroughly tested due to lack of our 
understanding regarding lineage-specific differentiation, homing and structural-functional 
integration of differentiated cell types in the host environment. To understand these 
mechanisms, it is desirable to have fluorescently-marked PSCs and their differentiated cell-
types, which could facilitate experimental cell transplantation studies.  
In this regard, our laboratory has earlier generated enhanced green fluorescent protein (EGFP)-
expressing FVB/N transgenic ‘green’ mouse: GU-3 line (Devgan et al., 2003). This transgenic 
mouse has been an excellent source of intrinsically green fluorescent cell types.  Recently, we 
have derived a ‘GS-2’ ES-cell line from the GU-3 mouse line (Singh et al., 2012). Additionally, 
we envisaged the need for developing an iPS-cell line from the GU-3 mouse and then use them 
for studying cell differentiation. Thus, aims of the study described in the thesis are to: (1) 
develop an experimental system to derive EGFP-expressing fluorescently-marked iPS-cell line 
from a genetically non-permissive FVB/N mouse strain, characterize the established iPS-cell 
line and achieve differentiation of various cell types from EGFP-expressing iPS-cell line; (2) to 
study differentiation phenomenon, in particular to cardiac lineage, using select-cardiogenesis   
          modulators and (3) to assess the gene-expression profiles and signaling system associated 
with cardiomyocyte differentiation of PSCs.   
This thesis is divided into four chapters with the 1
st
 chapter being a review of literature followed 
by three data chapters. In the chapter I of the thesis, a comprehensive up-todate review of 
literature is provided pertaining to PSCs, their classification, derivation strategies especially for 
reprogramming of somatic cells for iPSC generation, their differentiation potential and 
characterization, particularly to cardiac lineage. Various molecular regulators involved in 
cardiac differentiation of PSCs with emphasis on epigenetic regulation involving DNA 
methylation and signaling pathways involved are described in detail. Subsequently, various 
approaches used for enhanced cardiac differentiation of PSCs and the therapeutic potential of 
PSC-derived differentiated cell types to treat disease(s) are discussed.   
Chapter-II describes the successful establishment of a permanent iPS-cell line (named ‘N9’ iPS-
cell line) from the non-permissive FVB/N EGFP-transgenic GU-3 ‘green’ mouse. This chapter 
provides results pertaining to detailed derivation strategy and characterization of the ‘N9’ iPS-
cell line which includes colony morphology, expansion (proliferation) efficiency, alkaline 
phosphatase staining, pluripotent markers’ expression analysis by qPCR and immunostaining 
approaches and karyotyping analysis. Further, in order to thoroughly assess the differentiation 
competence of the ‘N9’ iPScell line, assessment of in-vitro and in-vivo differentiation potential 
of the ‘N9’ iPS-cell line by embryoid body (EB) formation and teratoma formation in nude mice 
and its detailed histological analysis showing three germ layer cell types and their derivatives 
were performed, followed by the generation of chimeric blastocysts by aggregation method. 
This established N9 iPS-cell line could potentially offer a suitable model system to study 
cardiac differentiation along with other established PSC lines such as the GS-2 and D3 ES-cell 
lines and the P19 EC-cell line.   
Following the establishment of the system to study cardiac differentiation of PSC lines, efforts 
were made to understand the biology of cardiac differentiation of PSCs (wildtype and EGFP-
transgenic PSC lines and P19 EC-cell line) using small molecules as           
modulators. Data pertaining to this is described in Chapter-III. The possible involvement of 
epigenetic regulation of cardiogenesis for example, DNA methylation changes in cardiogenesis-
associated genes is studied using 5-aza cytidine as one of the chromatin modifiers. In order to 
understand the cardiac differentiation phenomenon, as a consequence of using 5-aza cytidine in 
cell culture, it was important to investigate its ability to induce/mediate cardiac differentiation. 
This involved an assessment by quantitating the cardiac beating phenotype and correlating this 
with enhanced cardiac-gene expression profiles. Further, DNA methylation regulation of 
cardiogenesisassociated genes is described using various DNA methylation analysis techniques. 
Moreover, the possible involvement of other signaling members in mediating the cardiac 
differentiation is also studied using the P19 EC-cells. Results pertaining to the above findings 
are described in detail in the Chapter-III.  
Chapter-IV is focused on various efforts made towards investigating the ability of ascorbic acid 
to enhance cardiac differentiation of mouse ES-cells (GS-2 and D3 lines). Ascorbic acid has 
been implicated to be influencing cardiogenesis and it is reported to enhance differentiation of 
various cell types under certain culture conditions. Results pertaining to enhancement of cardiac 
differentiation of PSCs using ascorbic acid are presented in this chapter. This included 
assessment by quantitating cardiac beating phenotype and its correlation with enhanced 
cardiogenesis-associated gene expression profiles. Besides, estimation on the sorted 
cardiomyocyte population, derived from PSCs was also made using mature-cardiac marker. The 
possible underlying signaling mechanism involved was also studied in detail, using specific 
inhibitors for pERK (U0126), integrin signaling (pFAK; PP2) and collagen synthesis (DHP), in 
order to ascertain their involvement in ascorbic acid-mediated cardiac differentiation of mouse 
ES-cells. Subsequent to the three data chapters (II-IV), separate sections are provided for 
‘Summary and Conclusion’ and for ‘Bibliography’, cited in the thesis. The overall scope of the 
study has been to understand the basic biology of cardiac differentiation from PSCs (EC-cells, 
iPS-cells and transgenic and wild-type ES-cells) and to assess, by using certain small molecules, 
whether PSCs could be coaxed to enhance the differentiation to a particular cell type (cardiac). 
The data contained in this thesis addresses the above theme.  
